MIRA INFORM REPORT

 

 

Report Date :

03.01.2011

 

Note:

Registered office of the company has been shifted from # 210, My Home Tycoon 6-3-1192, Kundanbagh, Begumpet, Hyderabad-500016, Andhra Pradesh, India to the present address w.e.f.04.11.2009    

 

IDENTIFICATION DETAILS

 

Name :

GVK BIOSCIENCES PRIVATE LIMITED

 

 

Registered Office :

Plot No.28 A, IDA Nacharam, Hyderabad-500 076, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

01-35826

 

 

Com. Reg. No.:

07.12.2000

 

 

CIN No.:

[Company Identification No.]

U74999AP2000PTC035826

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDG00774E

 

 

PAN No.:

[Permanent Account No.]

AABCG3208J

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Provide contract research services to base of global pharmaceutical and biotechnology companies.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (53)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 9500000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company having fine track. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Shiva

Designation :

Accounts Department

Date :

31.12.2010

 

 

LOCATIONS

 

Registered Office :

Plot No.28 A, IDA Nacharam, Hyderabad-500 076, Andhra Pradesh, India

Tel. No.:

91-40-66929999

Fax No.:

91-40-66929900

E-Mail :

gvkbio@gvk.com

rajesh@gvkbio.com

compliances@gvkbio.com

info@gvkbio.com

Website :

http://www.gvkbio.com

 

 

Administrative Offices :

7th Floor, Swarna Jayanthi Commercial Complex, Ameerpeet, Hyderabad – 540 038, Andhra Pradesh, India

Tel No:

91-40-66628888 / 66635555

 

 

Overseas Offices:

Located At:

 

·         Singapore

·         US

 

 

DIRECTORS

 

As on 11.06.2010

Name :

Mr. Davinder Singh Brar

Designation :

Chairman

Address :

Greenfields Farm, Gadalpur- Jaunapur road, Village, Jaunapur, Tehsil- Mehrauli, New Delhi-110 030, Delhi, India

Date of Birth/Age :

21.08.1952

Date of Appointment :

26.07.2004

 

 

Name :

Mr. Gunapati Venkata Sanjay Reddy

Designation :

Director

Address :

H No.6-3-1089/A/5, Rajbhavan Road, Somaji Guda, Hyderabad-500482, Andhra Pradesh, India

Date of Birth/Age :

16.11.1964

Date of Appointment :

07.12.2000

 

 

Name :

Mr. Gunapati Indira Krishna Reddy

Designation :

Director

Address :

H No.6-3-250, Road No.1, Banjara Hills, Hyderabad-500034, Andhra Pradesh, India

Date of Birth/Age :

17.10.1944

Date of Appointment :

07.06.2002

 

 

Name :

Mr. Sandeep Singhal

Designation :

Director

Address :

C -76, Diamond District, Air Port Road, Bangalore – 560 017, Karnataka, India

Date of Birth/Age :

31.12.1969

Date of Appointment :

08.11.2007

 

 

Name :

Professor Tarun Khanna

Designation :

Director

Address :

66, Druid Hill Road, Newton-02461, USA

Date of Birth/Age :

09.05.1966

Date of Appointment :

19.06.2009

 

 

Name :

Mr. Gerhard Mayr 

Designation :

Director

Address :

95, Eaton Square, London SW1W9AQ, UK

Date of Birth/Age :

05.12.1946

Date of Appointment :

21.07.2009

 

 

Name :

Mr. Krishna Ram Bhupal

Designation :

Director

Address :

House No.6-3-250/1, Road No.1, Banjara Hills, Hyderabad-400 018, Andhra Pradesh, India

Date of Birth/Age :

16.03.1983

Date of Appointment :

20.10.2009

 

 

Name :

Mr. Ahay Kumar Pandey

Designation :

Alternate Director to Sandeep Singhal

Address :

1402 Purna, Pochakhanwala Road, Worli Sea Face, Mumbai-400 018, Maharashtra, India

Date of Birth/Age :

01.12.1971

Date of Appointment :

21.07.2009

 

 

Name :

Mr. Somanadri Bhupal

Designation :

Director

Address :

House No.6-3-250/1, Road No.1, Banjara Hills, Hyderabad-400 018, Andhra Pradesh, India

Date of Birth/Age :

17.01.1956

Date of Appointment :

01.09.2009

 

 

KEY EXECUTIVES

 

Name :

Mr. K. Ramkrishna

Designation :

Company Secretary

Address :

505, Saipriya Apartments, LIC Colony, Gudimalkapur, Hyderabad-500 028, Andhra Pradesh, India

Date of Birth/Age :

09.03.1968

Date of Appointment :

06.12.2007

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 11.06.2010

Names of Shareholders

 

No. of Shares

G. V. Sanjay Reddy

 

978750

G. V. Krishna Reddy

 

407814

G. Indira K Reddy

 

407811

Shalini Bhupal

 

407811

G. Aparna Reddy

 

652500

GVK Davix Technologies Private Limited, India

 

8475000

Devinder singh Brar

 

3262500

Sequoia Capital india Growth Investment Holdings, Mauritius

 

1545000

Shriya Bhupal

 

203907

Krishna Ram Bhupal

 

203907

Total

 

16545000

 

As on 11.06.2010

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

9.34

Bodies corporate

 

51.22

Directors or relatives of directors

 

39.44

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Provide contract research services to base of global pharmaceutical and biotechnology companies.

 

 

GENERAL INFORMATION

 

No. of Employees :

500 (Approximately)

 

 

Bankers :

  • Kotak Mahindra Bank Limited, 36-38A, Nariman Bhavan, 227, D, Nariman Point, Mumbai-400021, Maharashtra, India (w.ef.29.01.2001)

 

  • Canara Bank, Prime Corporation Branch, TSR Complex, SP Road, Secunderabad-500003, Andhra Pradesh, India

 

  • YES Bank Limited

       Address: 9th Floor, Nehru Centre, Discovery of India, Dr. Annie Besant   Road, Worli, Mumbai – 400 018, Maharashtra, India

 

  • ICICI Bank Limited

 

  • Rabo Bank, Singapore

 

 

Facilities :

Secured Loans :

 

As on 31.03.2010

Rs. in Millions

As on 31.03.2009

Rs. in Millions

Term Loan (Payable within one year Rs.51.781 millions)

103.562

176.297

Working Capital Loans

204.716

280.689

Foreign Currency Packing Credit and buyers credit loan

254.229

234.058

Total

562.507

691.044

 

Note:

1)       Term loan from Raboabnk, Singapore is secured by way of first charge on the company’s fixed assets, present and future, including capital work in progress and exclusive charge on receivables of specific customer

2)       Working capital loans from Canara Bank and Kotak Mahindra Bank, foreign currency packing credit loans from Standard Chartered Bank, Citibank NA and Kotak Mahindra Bank are secured by first charge on current assets including other receivables and second charge on all fixed assets of the company.

 

 

 

Banking Relations :

-

 

 

Auditors :

 

Name :

Walker, Chandiok and Company

Chartered Accountants

Address :

3rd Floor, Uptown Banjara, Road No. 3, Banjara Hills, Hyderabad-500 034, Andhra Pradesh, India

Tel. No.:

91-40-64528666

Fax No.:

91-40-23540224

E-Mail :

hyderabad@wcgt.in

 

 

Holding Company :

GVK Davix Technologies Private Limited

 

CAPITAL STRUCTURE

 

As on 11.06.2010

Authorised Capital :

No. of Shares

Type

Value

Amount

20000000

Equity Shares

Rs.10/- each

Rs.200.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

16545000

Equity Shares

Rs.10/- each

Rs.165.450 millions

 

Note:

 

Of the above equity shares

 

5000000 shares of Rs.10/- each fully paid up were allotted as bonus shares by capitalization of balalnce in the profit and loss account.

8475000 shares are held by Holding Compnay GVK Davix Technologies Private Limited

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

165.450

165.450

165.450

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

2207.685

1892.090

1669.005

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

2373.135

2057.540

1834.455

LOAN FUNDS

 

 

 

1] Secured Loans

562.507

691.044

607.633

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

562.507

691.044

607.633

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

2935.642

2748.584

2442.088

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

1354.059

1364.038

1270.779

Capital work-in-progress

225.737

181.393

168.374

 

 

 

 

INVESTMENT

182.485

221.459

444.944

DEFERREX TAX ASSETS

4.404

0.000

67.297

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

21.177

24.939

18.472

 

Sundry Debtors

552.921

535.367

352.226

 

Cash & Bank Balances

365.013

288.628

65.325

 

Other Current Assets

4.971

3.685

0.122

 

Loans & Advances

527.422

402.608

323.495

Total Current Assets

1471.504

1255.227

759.640

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

178.048

158.972

192.175

 

Other Current Liabilities

80.428

78.056

43.479

 

Provisions

44.071

36.505

34.507

Total Current Liabilities

302.547

273.533

270.161

Net Current Assets

1168.957

981.694

489.479

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

2935.642

2748.584

2442.088

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

2266.076

2126.841

 

 

Other Income

68.068

48.628

 

 

 

TOTAL                                     (A)

2334.144

2175.469

1802.072

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of revenue

514.702

482.971

 

 

Personnel Expenses

654.620

585.882

1243.018

 

 

General and administrative Expense

539.366

545.101

 

 

 

TOTAL                                     (B)

1708.688

1613.954

1243.018

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

625.456

561.074

559.054

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

44.724

59.212

78.152

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

580.732

501.862

480.902

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

236.536

209.872

155.078

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

344.196

292.431

325.824

 

 

 

 

 

Less

TAX                                                                  (H)

11.802

40.401

9.835

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

332.394

252.030

315.989

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

914.391

695.718

399.086

 

 

 

 

 

 

Adjustment for change in accounting policy

0.000

(14.000)

0.000

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend

19.854

16.545

NA

 

 

Dividend Tax

3.297

2.812

NA

 

 

Transfer to General Reserve

8.310

0.000

NA

 

BALANCE CARRIED TO THE B/S

1215.324

914.391

395.718

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

 

 

 

Basic

20.09

15.23

NA

 

Diluted

19.93

15.23

NA

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

14.24

11.59

17.53

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

15.19

13.75

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.18

11.16

16.05

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.15

0.14

0.18

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.36

0.47

0.48

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

4.86

4.59

2.81

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Details of Sundry Creditors:

 

Particulars

 

31.03.2010

(Rs. in millions)

31.03.2009

(Rs. in millions)

31.03.2008

(Rs. in millions)

Sundry Creditors

 

 

 

Total outstanding dues of Micro Enterprise and Small Enterprises

-

-

-

Total outstanding dues of creditors other than Micro Enterprises and small enterprises

178.048

158.972

192.175

 

 

PERFORMANCE

 

Environment

 

The Financial Year 2009-10 began with the continuing recession in the global markets more particularly in the US and with some significant consolidations in the Pharma industry in the light of lower growth projections due to patent expiries and cost and pricing pressures resulting from economic downturn and regulatory reforms. To benefit from the cost advantages and for accelerated research, Pharma companies continued to increase frequency and level of sophistication in outsourcing during the year, and the slowdown witnessed by the CR0 industry from the latter hail of the previous year was on the wane.

 

Performance

 

During the year, the Company achieved a turnover of Rs.2334.144 millions, a growth of 7.3% over the previous year and generated Profits after tax of Rs.332.394 millions.

 

In continuous pursuit of the Mission to “Deliver value-added scientific services with speed and quality”, the Company has focused on strengthening its operations, offering value-added and integrated services and on exceeding the quality, productivity and delivery expectations of its clients. The Company enjoys preferred vendor status with many clients in more than one area of business.

 

Company overview:

 

Subject is a Contract Research Organisation having a global client base, providing contract services to rapidly growing base of global pharmaceutical and biotechnology companies. The Company combines science; innovation and people to help clients address their drug development challenges. The Company was incorporated 07 December 2000 in Hyderabad, Andhra Pradesh, India Bankers Charges Report as per Registry

 

Bankers Charges Report as per Registry

 

Name of the company

GVK BIOSCIENCES PRIVATE LIMITED

Presented By

Mr. Rajesh G Company Secretary

1) Date and description of instrument creating the change

Common hypothecation agreement dated 06.09.2004.

2) Amount secured by the charge/amount owing on the securities of charge

Term Loan of Rs.205.800 millions with a sub limit for LC Rs.80.000 millions, OCC/ODBD limit of Rs.25.000 millions with a sublimit for Letter of Credit.

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

For term loan – First charge on fixed assets movable and immovable existing and proposed to be acquired under loan including EMT of the two landed properties proposed to be purchased at Bangalore and Hyderabad.

 

Second charge on stocks and receivables.

 

For working capital limits – First charge on stocks and receivable and second charge on fixed assets present and future.

4) Gist of the terms and conditions and extent and operation of the charge.

Term loan repayable in 60 equal monthly installments as detailed in Canara Bank Sanction letter at an interest rate of 7% per annum.

 

Working capital limit with a interest rate of 8% per annum.

5) Name and Address and description of the person entitled to the charge.

Canara Bank, Industrial Finance Branch,

S P Road, Secunderabad-500003.

6) Date  and brief description of instrument modifying the charge

Counter Indemnity for Bank Guarantee dated 28.09.2004

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

Bank guarantee of Rs. 5.000 millions is sanctioned.

 

There is no change in the limits as well as all other terms and conditions.

 

 

Corporate identity number of the company

U74999AP2000PTC035826

Name of the company

GVK BIOSCIENCES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Plot No.28 A, IDA Nacharam, Hyderabad-500 076, Ahdhra Pradesh, India

This form is for

Modification of charge

Type of charge

Book Debts

Immovable Property

Others

Stocks 

Particular of charge holder

Canara Bank, Prime Corporation Branch, TSR Complex, SP Road, Secunderabad-500003, Andhra Pradesh, India

Nature of description of the instrument creating or modifying the charge

Supplemental Common Hypothecation Agreement dated 30th  June 2010

Date of instrument Creating the charge

30.06.2010

Amount secured by the charge

Rs.157.000 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

 OCC/ODBD: BPLR (Floating), presently 12.00% p.a.

PC/FDB/FBE : as applicable, 9.5% p.a. (floating) at present

PCFC/BRD : LIBOR Plus 350 bps

 

Terms of Repayment

Interest to be recovered from the funds provided in the Account.

 

Margin

For OCC/ODBD - 25% on Stocks and Receivables excluding receivables from Wyeth Pharmaceuticals Inc.

for PC/PCFC/FDB/FBE/BRD - 10% on Stocks and Receivables excluding receivables from Wyeth Pharmaceuticals Inc.

for Bank Guarantee - 10% cash margin in the form of an FD with the Bank

 

Extent and Operation of the charge

Paripassu I charge on Stocks and Receivables valued as per stock statement dated 31.12.2009  excluding receivables from Wyeth Laboratories Limited(now Pfizer Inc.); Paripassu II charge on Fixed Assets of the Company (excluding Land and Buildings and intangible assets including capital work in progress WDV value as per PBS31.03.09; Paripassu I charge by way of EMT of the landed property situated at Plot No.284-A, Bommasandra-Jigani link road, Bangalore valued as per PBS 31.03.09 with superstructure

Short particulars of the property charged

The whole of the Borrower's Stocks and Receivables excluding receivables of Wyeth Laboratories Limited,

whole of the Borrower's Fixed Assets excluding Land and Buildings and Intangible assets

 

 Paripassu II charge on Fixed Assets of the Company (excluding Land and Buildings and intangible assets including capital work in progress WDV value as per PBS 31.03.09

 

Equitable Mortgage of Landed property situated at Plot No.284-A, Bommasandra - Jigani Link Road, Bangalore

Date of latest modification prior to the present modification

19.07.2008

Particulars of the present modification 

OCC/ODBD limits enhanced from Rs.130.000 millions to Rs. 142.000 millions and Bank Guarantee limits increased from Rs. 5.000 millions to Rs. 15.000 millions.

 

Fixed Assets:

 

·         Land

·         Building

·         Plant and Machinery

·         Laboratory Equipment

·         Computer

·         Air conditioner

·         Office Equipment

·         Vehicle

·         Leasehold Improvement

 


CMT REPORT (Corruption, Money Laundering and Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.81

UK Pound

1

Rs.69.29

Euro

1

Rs.59.81

 

SCORE and RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

53

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.